Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1977; 70(Suppl 1): 18–19.
PMCID: PMC1542860

Miconazole in systemic candidiasis.


Based on our experience with our first patients, miconazole is now the drug of choice in cases of systemic and pulmonary candidal infection. Initially we prefer the parenteral route of administration which is continued for only one or two weeks after a negative finding in culture. The dosage is 1.2 g per day for a 70 kg patient. Thereafter the treatment is continued orally for another four weeks. Miconazole is well documented as a drug without serious side-effects, but the incidence of candidal infections in about 1% of our surgical patients does not justify its prophylactic administration. Like antibiotics, miconazole is given only when there is a clinical manifestation and a positive finding in culture.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (494K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • ANDRIOLE VT, KRAVETZ HM, ROBERTS WC, UTZ JP. Candida endocarditis. Clinical and pathologic studies. Am J Med. 1962 Feb;32:251–285. [PubMed]
  • Clayton YM. Therapy of fungal infections. Br J Dermatol. 1973 Oct;89(4):423–425. [PubMed]
  • Fauser U. Erfolgreiche Therapie einer Candida-Sepsis mit interstitieller Pilzpneumonie. Dtsch Med Wochenschr. 1973 Jun 15;98(24):1207–1211. [PubMed]
  • Daneels R, Demeyere R, Eggers L, Lust P, van Landuyt H, Symoens J. Zur Behandlung systemischer Candidiasis mit Miconazol. Med Welt. 1974 Mar 8;25(10):428–429. [PubMed]
  • Fransen G, Van Camp K. Les candidoses rénales et urothéliales. Acta Urol Belg. 1974 Oct;42(4):452–471. [PubMed]
  • Hoeprich PD, Goldstein E. Miconazole therapy for coccidioidomycosis. JAMA. 1974 Nov 25;230(8):1153–1157. [PubMed]
  • Holt RJ. Recent developments in antimycotic chemotherapy. Infection. 1974;2(2):95–107. [PubMed]
  • Huijgens PC, Boeijinga JK, van der Meer J. Een mogelijk cardiotoxische reactie van miconazol-injectievloeistof. Ned Tijdschr Geneeskd. 1975 Oct 4;119(40):1549–1551. [PubMed]
  • Levine HB, Stevens DA, Cobb JM, Gebhardt AE. Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro. J Infect Dis. 1975 Oct;132(4):407–414. [PubMed]
  • Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery GS. Miconazole: a review of its antifungal activity and therapeutic efficacy. Drugs. 1975;9(6):406–423. [PubMed]
  • Stevens DA, Levine HB, Deresinski SC. Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med. 1976 Feb;60(2):191–202. [PubMed]
  • Van Cutsem JM, Thienpont D. Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy. 1972;17(6):392–404. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press